secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001493152-25-001214
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health interim CFO John Kallassy resigns; CEO becomes principal accounting officer
--------------------------------------------------------------------------------

- John Kallassy resigned as Interim CFO effective January 10, 2025, for personal reasons.
- CEO Dr. Sandra Milligan will serve as principal accounting officer until a permanent CFO is appointed.
- Board reinstated Dr. Milligan's full salary retroactive to December 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/0001493152-25-001214-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000149315225001214/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001214

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer